Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoHealth (GOCO) Cost of Revenue (2019 - 2025)

Historic Cost of Revenue for GoHealth (GOCO) over the last 7 years, with Q3 2025 value amounting to $20.1 million.

  • GoHealth's Cost of Revenue rose 209.32% to $20.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $144.0 million, marking a year-over-year increase of 2055.23%. This contributed to the annual value of $130.6 million for FY2024, which is 1783.39% down from last year.
  • According to the latest figures from Q3 2025, GoHealth's Cost of Revenue is $20.1 million, which was up 209.32% from $32.4 million recorded in Q2 2025.
  • In the past 5 years, GoHealth's Cost of Revenue registered a high of $99.9 million during Q4 2021, and its lowest value of $19.7 million during Q3 2024.
  • For the 5-year period, GoHealth's Cost of Revenue averaged around $42.5 million, with its median value being $39.3 million (2025).
  • Its Cost of Revenue has fluctuated over the past 5 years, first surged by 10765.87% in 2021, then plummeted by 7934.75% in 2022.
  • Over the past 5 years, GoHealth's Cost of Revenue (Quarter) stood at $99.9 million in 2021, then tumbled by 79.35% to $20.6 million in 2022, then skyrocketed by 99.16% to $41.1 million in 2023, then grew by 27.14% to $52.2 million in 2024, then plummeted by 61.53% to $20.1 million in 2025.
  • Its Cost of Revenue was $20.1 million in Q3 2025, compared to $32.4 million in Q2 2025 and $39.3 million in Q1 2025.